Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic GPO Saquinavir and Norvir Versus Invirase and Norvir
NCT00622141Phase 2Withdrawn
- Sponsor
- HIV-NAT
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of saquinavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Status: withdrawn.
02
Drugs
saquinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00622141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622141.